SALT LAKE CITY, Nov. 29, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes, today ...
Peer-reviewed results in Molecular Therapy Oncology show that targeted, mutation-agnostic CRISPR gene editing of NRF2 in head and neck cancer models resensitizes treatment resistant tumors to ...
Research published today in the Journal of Hepatology suggests that the protein responsible for antioxidant defenses in humans may adversely affect the liver. The research was led by postdoctoral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results